---  
layout: startup_page  
title: "TRIO Pharmaceuticals"  
id: "triopharmaceuticals.com"  
permalink: "/triopharmaceuticalstriopharmaceuticals.com12032024/"  
website: "https://www.triopharmaceuticals.com/"  
funding_round: "Pre-Series A"  
funding_amount: "$3.1M"  
investors: "Friedman Bioventure Fund (FBVF), Multiple Myeloma Research Foundation (MMRF) through its Myeloma Investment Fund (MIF), NuFund Venture Group, Life Science Angels"  
about: "TRIO Pharmaceuticals is a biotechnology company developing bispecific antibodies for cancer treatment. Their proprietary TRAILBody™ and TIE-ADC™ platforms combine targeted tumor growth inhibition with immune system modulation for potent, less toxic therapies. This approach addresses high unmet medical needs in cancers like multiple myeloma and leukemia."  
markets: "Biotechnology, Cancer Therapeutics, Immunotherapy, Health Care, Medical, Therapeutics, Drug Discovery, Life Sciences, Oncology"  
hq: "San Diego, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/trio-pharmaceutials-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/trio-pharmaceuticals-inc"  
pitchbook: "https://pitchbook.com/profiles/company/492890-41"  

date_display: "03-Dec-2024"  
date: "2024-12-03"

# SEO Optimization  
meta_title: "TRIO Pharmaceuticals - Pre-Series A Funding ($3.1M)"  
meta_description: "TRIO Pharmaceuticals, TRIO Pharmaceuticals is a biotechnology company developing bispecific antibodies for cancer treatment. Their proprietary TRAILBody™ and TIE-ADC™ platf..."  
meta_keywords: "TRIO Pharmaceuticals, Biotechnology, Cancer Therapeutics, Immunotherapy, Health Care, Medical, Therapeutics, Drug Discovery, Life Sciences, Oncology, Pre-Series A funding"  
canonical_url: "https://startup.projectstartups.com/triopharmaceuticalstriopharmaceuticals.com12032024/"  
---